We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Prospective Study of Liver Cancer Risk Shows Value of Circulating microRNAs

By LabMedica International staff writers
Posted on 16 Jun 2016
Print article
Image: A micrograph of hepatocellular carcinoma from a liver biopsy (Photo courtesy of Wikimedia Commons).
Image: A micrograph of hepatocellular carcinoma from a liver biopsy (Photo courtesy of Wikimedia Commons).
A prospective study conducted on a group of individuals who had been infected with hepatitis B virus (HBV) has shown that a panel of 15 microRNAs (miRNAs) could predict high or low risk of developing liver cancer (hepatocellular carcinoma).

The predictive value of circulating miRNAs in HBV-related hepatocellular carcinoma (HCC) has been demonstrated in retrospective studies, but it has rarely been tested in prospective studies. To help correct this deficiency, investigators at Thomas Jefferson University (Philadelphia, PA, USA) measured the expression of 24 retrospectively identified HCC-related miRNAs in baseline serum samples collected from a cohort of 373 cancer-free HBV patients. The patients were monitored for 4.5 years.

Results published in the May 24, 2016, online edition of the journal Oncotarget revealed that during the follow-up period 40 of the patients developed liver cancer.

When the investigators analyzed the prospective associations of miRNA expression with HCC risk using the Cox proportional hazards model, they found that 15 of the 24 miRNAs – miRNAs that targeted genes mainly enriched in the transforming growth factor-beta signaling pathway – exhibited a significant association with HCC risk. In particular, seven miRNAs (miR-122, miR-99a, miR-331, miR-125b, miR-23b, miR-92a, and miR-26a) were associated with an increased risk, and eight miRNAs (miR-652, miR-23a, miR-27a, miR-34a, miR-145, miR-10a, miR-150, and let-7f) were associated with a decreased risk. Knowledge of the risk score significantly increased the HCC prediction performance of the frequently used alpha-fetoprotein analysis method.

"We need to find more microRNAs that may predict liver cancer in order to sharpen this tool for identifying high risk patients," said senior author Dr. Hushan Yang, associate professor of medical oncology at Thomas Jefferson University. "Through collaboration with Dr. Hie-Won Hann in the department of medicine at Thomas Jefferson University, we continue to work on improving this diagnostic method."

Related Links:
Thomas Jefferson University

Gold Member
Fully Automated Cell Density/Viability Analyzer
BioProfile FAST CDV
Verification Panels for Assay Development & QC
Seroconversion Panels
New
Toxoplasma Gondii Immunoassay
Toxo IgM AccuBind ELISA Kit
New
Mycoplasma Pneumoniae Virus Test
Mycoplasma Pneumoniae Virus Detection Kit

Print article

Channels

Molecular Diagnostics

view channel
Image: Researcher Kanta Horie places a sample in a mass spectrometer that measures protein levels in blood plasma and other fluids (Photo courtesy of WashU Medicine)

Highly Accurate Blood Test Diagnoses Alzheimer’s and Measures Dementia Progression

Several blood tests are currently available to assist doctors in diagnosing Alzheimer's disease in individuals experiencing cognitive symptoms. However, these tests do not provide insights into the clinical... Read more

Immunology

view channel
Image: The findings were based on patients from the ADAURA clinical trial of the targeted therapy osimertinib for patients with NSCLC with EGFR-activated mutations (Photo courtesy of YSM Multimedia Team)

Post-Treatment Blood Test Could Inform Future Cancer Therapy Decisions

In the ongoing advancement of personalized medicine, a new study has provided evidence supporting the use of a tool that detects cancer-derived molecules in the blood of lung cancer patients years after... Read more

Microbiology

view channel
Image: Schematic representation illustrating the key findings of the study (Photo courtesy of UNIST)

Breakthrough Diagnostic Technology Identifies Bacterial Infections with Almost 100% Accuracy within Three Hours

Rapid and precise identification of pathogenic microbes in patient samples is essential for the effective treatment of acute infectious diseases, such as sepsis. The fluorescence in situ hybridization... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.